Live Breaking News & Updates on Xiaoyu Zhou

Stay updated with breaking news from Xiaoyu zhou. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Caught by the Tail – Yale Scientific Magazine

Caught by the Tail – Yale Scientific Magazine
yalescientific.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from yalescientific.org Daily Mail and Mail on Sunday newspapers.

Xiaoyu Zhou , Yale University , Sidi Lab , Image Courtesy , Nature Immunology ,

Tail spin: Study reveals new way to reduce friendly fire in cell therapy

Tail spin: Study reveals new way to reduce friendly fire in cell therapy
sciencedaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from sciencedaily.com Daily Mail and Mail on Sunday newspapers.

Hanbing Cao , Sidi Chen , Xiaoyu Zhou , Us Department Of Defense , National Institutes Of Health , Yale Center , Yale Cancer Center , Yale School Of Medicine , Systems Biology Institute , Yale Stem Cell Center , Yale School , Biomedical Data Science , Cancer Systems Biology , National Institutes ,

Engineered 'tails' tame killer T cells for immunotherapy

Fusing a molecular tail onto the engineered T cells used in immunotherapy can inhibit their proclivity to attack each other, say researchers. ....

Sidi Chen , Hanbing Cao , Xiaoyu Zhou , Us Department Of Defense , National Institutes Of Health , Yale University School Of Medicine , Yale University School , National Institutes ,

Tail spin: Study reveals new way to reduce fr

In a promising form of immunotherapy known as CAR T-cell (chimeric antigen receptor) therapy, the patient’s T cells are engineered to better recognize and attack antigens on the surface of cancer cells. In treatments currently approved for use in battling lymphoma and leukemia, however, the therapy has a drawback: Amidst the cancer-killing frenzy, many engineered T cells become tainted with the remnants of cancer antigens, which causes them to turn on other T cells. This eventually depletes the body of cancer-fighting cells and opens the door for a recurrence of cancer.

A new Yale study, however, has identified a way to tame the self-destructive tendencies of these killer T cells. Simply fusing a molecular tail onto the engineered T cells used in therapy, researchers say, can inhibit their proclivity to attack each other. The study was published July 27 in the journal Nature Immunology. ....

Hanbing Cao , Sidi Chen , Xiaoyu Zhou , Yale Stem Cell Center , Yale School Of Medicine , Systems Biology Institute , Yale Center , National Institutes Of Health , Us Department Of Defense , Yale Cancer Center , New Haven , Yale School , Biomedical Data Science , Cancer Systems Biology , National Institutes ,